{
 "name": "美吾華",
 "slug": "tw-1731",
 "aliases": [
  "美吾華股份有限公司",
  "Maywufa",
  "1731"
 ],
 "ticker": "1731",
 "industry": "生技醫療業",
 "website": "http://www.maywufa.com.tw",
 "summary": "美吾華（1731）是上市的生技醫療類股公司，1976 年成立，2001 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "美吾華股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "Maywufa",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2001-09-17",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "1976-10-01",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "李成家",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "賴育儒",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 1329152440,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "http://www.maywufa.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 142282,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 9.68,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 9.26,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "管線：SAHOLEA（森歐黎漾洗護系列）",
   "value": "洗髮與護髮｜已上市化粧品；列於2025年開發成功產品｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "公司主要產品盤點；屬化粧品，非新藥或藥品許可。年報記載100品項但未逐項列明全部SKU。"
  },
  {
   "claim": "管線：INNEX（植萃賦活系列）",
   "value": "洗髮與護髮｜已上市化粧品；列於2025年開發成功產品｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "公司主要產品盤點；屬化粧品，非新藥或藥品許可。年報記載100品項但未逐項列明全部SKU。"
  },
  {
   "claim": "管線：BlackVerse（賦活喚黑系列）",
   "value": "髮品保養｜已上市化粧品；列於2025年開發成功產品｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "公司主要產品盤點；屬化粧品，非新藥或藥品許可。年報記載100品項但未逐項列明全部SKU。"
  },
  {
   "claim": "管線：美吾髮植優染髮系列",
   "value": "染髮｜已上市化粧品；列於2025年開發成功產品｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "公司主要產品盤點；屬化粧品，非新藥或藥品許可。年報記載100品項但未逐項列明全部SKU。"
  },
  {
   "claim": "管線：美吾髮妍粋泡泡染",
   "value": "染髮｜已上市化粧品；列於2025年開發成功產品｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "公司主要產品盤點；屬化粧品，非新藥或藥品許可。年報記載100品項但未逐項列明全部SKU。"
  },
  {
   "claim": "管線：PG2（懷特血寶凍晶注射劑；代理產品）",
   "value": "癌因性疲憊症｜台灣已核准上市並經銷；非本公司自研藥｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "原開發商為懷特生技新藥；美吾華醫藥事業負責代理／經銷。年報載衛福部核准及健保給付，但未列完整許可證號與首次日期，不另建產品許可fact。"
  },
  {
   "claim": "管線：Cerebrolysin（速利清注射劑；代理產品）",
   "value": "腦中風、腦外傷及相關神經併發症之公司所述臨床用途｜已代理銷售｜台灣",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.maywufa.com.tw/uploads/images/Investor/ShareholdersMeeting/114_Annual_CN_Final.pdf",
   "note": "年報所述臨床研究與銷售用途，未據此宣稱新的核准適應症；藥品供應與經銷對象Ever Neuro Pharma GmbH不是新IP授權交易。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1731.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}